We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$87.8M
1-Year Est. Return
27.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.79%
1 Year Est. Return
+27.76%
3 Year Est. Return
+120.76%
5 Year Est. Return
+150.7%
10 Year Est. Return
–
AUM
$85.9M
AUM Growth
+$6.07M
(+7.6%)
Cap. Flow
-$2.29M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
45.9%
Holding
119
New
26
Increased
15
Reduced
64
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADC Therapeutics
ADCT
|
+$3.02M |
| 2 |
BLCN
Siren ETF Trust Siren NexGen Economy ETF
BLCN
|
+$2.08M |
| 3 |
Commault Systems
CVLT
|
+$667K |
| 4 |
Intercontinental Exchange
ICE
|
+$525K |
| 5 |
Global X Lithium & Battery Tech ETF
LIT
|
+$515K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$2.29M |
| 2 |
Microsoft
MSFT
|
+$1.13M |
| 3 |
BlackRock Municipal 2030 Target Term Trust
BTT
|
+$1.1M |
| 4 |
Apple
AAPL
|
+$833K |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$768K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.09% |
| 2 | Technology | 15.8% |
| 3 | Consumer Discretionary | 8.16% |
| 4 | Communication Services | 5.61% |
| 5 | Financials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$1.02T
| $11.7M | 13.57% |
69,033
+340
| +0.5% | +$50.8K |
|
|
2
Apple
AAPL
$4.54T
| $6.75M | 7.85% |
50,846
-6,926
| -12% | -$833K |
|
3
Amazon
AMZN
$2.92T
| $3.86M | 4.49% |
23,700
-180
| -0.8% | -$28.7K |
|
4
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
| $3.79M | 4.41% |
57,266
-1,385
| -2% | -$82.3K |
|
|
5
ADC Therapeutics
ADCT
$134M
| $2.95M | 3.44% |
+92,287
| New | +$3.02M |
|
6
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
| $2.3M | 2.67% |
143,096
-7,944
| -5% | -$120K |
|
|
BLCN
7
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
| $2.29M | 2.67% |
+56,320
| New | +$2.08M |
|
8
Schwab US Dividend Equity ETF
SCHD
$103B
| $2.17M | 2.53% |
101,523
-4,605
| -4% | -$93.4K |
|
9
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
| $2.02M | 2.35% |
19,767
-4,670
| -19% | -$476K |
|
10
Meta Platforms (Facebook)
META
$1.42T
| $1.65M | 1.92% |
6,031
-317
| -5% | -$86.9K |
|
|
11
Microsoft
MSFT
$3.45T
| $1.5M | 1.75% |
6,766
-5,250
| -44% | -$1.13M |
|
|
12
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| $1.43M | 1.66% |
55,550
-44,000
| -44% | -$1.1M |
|
13
Teladoc Health
TDOC
$1.22B
| $1.42M | 1.65% |
7,104
-1,208
| -15% | -$246K |
|
14
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $1.27M | 1.48% |
3,399
-1,325
| -28% | -$470K |
|
15
Schwab US Broad Market ETF
SCHB
$43.2B
| $1.1M | 1.28% |
72,738
-6,000
| -8% | -$85.5K |
|
|
SLY
16
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $1.03M | 1.2% |
12,984
-2,537
| -16% | -$181K |
|
17
Visa
V
$684B
| $1.03M | 1.2% |
4,703
-388
| -8% | -$79.4K |
|
18
Royalty Pharma
RPRX
$25.9B
| $987K | 1.15% |
19,718
-3,570
| -15% | -$151K |
|
|
19
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
| $947K | 1.1% |
18,640
-15,125
| -45% | -$768K |
|
20
Pfizer
PFE
$143B
| $860K | 1% |
23,361
-4,290
| -16% | -$157K |
|
21
Schwab International Equity ETF
SCHF
$66.6B
| $819K | 0.95% |
45,478
-996
| -2% | -$16.8K |
|
22
Alphabet (Google) Class A
GOOGL
$4.36T
| $796K | 0.93% |
9,080
-2,960
| -25% | -$249K |
|
|
23
Commault Systems
CVLT
$4.88B
| $790K | 0.92% |
+14,275
| New | +$667K |
|
24
PepsiCo
PEP
$190B
| $774K | 0.9% |
5,218
-38
| -0.7% | -$5.4K |
|
25
American Tower
AMT
$80.8B
| $766K | 0.89% |
3,411
+2,141
| +169% | +$498K |
|
Similar funds
DG
XXIP
CVM
BCP
PM
PBCM
S2L
IC
Indie Asset Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Indie Asset Partners held 119 positions worth $85.9M, up 7.6% from $79.8M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Indie Asset Partners's Q4 2020 filing shows 26 new, 15 increased, 64 reduced and 10 closed positions. Its largest new stake was ADC Therapeutics: 92,287 shares worth $2.95M. The largest sale was ProShares Short S&P500, an estimated $2.29M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Indie Asset Partners's largest Q4 2020 buy was ADC Therapeutics: 92,287 shares worth $2.95M.
- Indie Asset Partners added most to American Tower in Q4 2020, an estimated $498K increase.
- Indie Asset Partners's biggest Q4 2020 reduction was Microsoft, cutting an estimated $1.13M.
- Indie Asset Partners fully exited ProShares Short S&P500 in Q4 2020, selling an estimated $2.29M.
- Indie Asset Partners's ten largest holdings make up 46% of its $85.9M portfolio in Q4 2020.
- Indie Asset Partners opened 26 new positions and closed 10 in Q4 2020.
- Indie Asset Partners's portfolio value rose 7.6% quarter-over-quarter to $85.9M.
Based on Indie Asset Partners's 13F filing for Q4 2020, filed 9 Feb 2021.